Skip to content

Bioequivalence of Vortioxetine 20 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509419-10-00
Acronym
CFA-1034-1-23
Enrollment
24
Registered
2024-05-03
Start date
2024-05-09
Completion date
2024-06-11
Last updated
2024-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition

Interventions

None listed

Sponsors

Laboratorios Cinfa S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026